Imaging and Characterizating Stress responses in vivo with p21 Reporter Mice
Imaging and Characterizating Stress responses in vivo with p21 Reporter Mice
批准号:
8195496
负责人:
David Piwnica-Worms
金额:
$11.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31
关键词:
Adverse effectsCaloric RestrictionCancer PatientCellsCessation of lifeChemoprotective AgentClinical TrialsClinical effectivenessDNA DamageDevelopmentDoseEffectivenessEngineeringEtoposideFastingFatigueFirefly LuciferasesFood deprivation (experimental)Genotoxic StressGrowthHeartHigh Dose ChemotherapyHypothalamic structureImageInstructionInterventionIonizing radiationKnockout MiceLiteratureMalignant neoplasm of prostateMediatingMetabolicMetabolismMolecularMusMutationNeuronsNeutropeniaNormal CellNormal tissue morphologyOrganPTEN genePathway interactionsPublishingRadiation therapyRadioReporterReportingRoleSignal PathwayStarvationTestingTherapeuticTimeTopoisomeraseToxic effectUniversitiesWashingtonXenograft procedurebiological adaptation to stresscancer cellcancer typechemotherapydietary restrictioneffective interventionfeedinggastrointestinalin vivoinhibitor/antagonistirinotecankillingsmolecular imagingmouse modelneoplastic cellnoveloncoprotein p21preconditioningprogramspromoterresearch studyresponsetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The full potential of chemotherapy can be limited in practice by toxic side effects. Therefore, strategies or
interventions that are effective in selectively protecfing normal cells, but not cancer cells, are predicted to
increase the therapeutic window and clinical effectiveness of chemotherapy. Published literature
demonstrates that mice subjected to short-term stan/ation are protected from high doses of etoposide that
kill their fed littermates. In addition, tumor cells carrying mutations that cause constitutive activation of the
PI3K pathway have been shown to be insensitive to the anti-growth effects of dietary restriction when grown
as xenografts in mice. Thus, fasting may enhance the effectiveness of chemotherapy by protecting normal
cells, but not cancer cells, frcim the toxic effects of chemotherapy and clinical trials are currently being
conducted to test whether fasting prior to or during chemotherapy reduces associated side-effects in cancer
patients. However, little is known about the molecular mechanisms mediating the differential response of
normal cells compared with cancer cells to short-term starvation. Using a reporter mouse engineered to
express firefly luciferase from the endogenous p21 promoter, we observe a potent induction of p21
expression in response to short-term stan/ation. Interestingly, this occurs in metabolic organs and p21
expression was also observed, forthe first time, in particular neurons ofthe hypothalamus that regulate
metabolism. Our preliminary studies also demonstrate that p21 protects cells from the DNA damaging effects
of irinotecan, a topoisomerase 1 inhibitor used clinically to treat certain types of cancer. Thus, experiments
proposed in this applicafion will (1) determine if induction of p21 expression by short-term starvation protects
mice from the lethal effects of high dose chemotherapy and ionizing radiation, (2) identify the signaling
pathway(s) responsible for activating p21 expression in response to short-term starvation and (3) determine
if short-term stan/ation protects mice, but not PTEN-deficient prostate cancers growing in these mice, from
chemotherapy and radiation therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
First-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter
-
批准号:10577531
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2023
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Core
-
批准号:10517142
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2022
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Core
-
批准号:10707122
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2022
-
负责人:David Piwnica-Worms
-
依托单位:
Administrative Core
-
批准号:8658378
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2014
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging Reporter
-
批准号:8195499
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Administrative Core
-
批准号:8195493
-
项目类别:
-
资助金额:$66.14万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Molecular Imaging High Throughtput Screening
-
批准号:8195501
-
项目类别:
-
资助金额:$6.35万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
PET Imaging of GVHD and GVL after treatment with Azacitidine
-
批准号:8195498
-
项目类别:
-
资助金额:$11.47万
-
财政年份:2012
-
负责人:David Piwnica-Worms
-
依托单位:
Core A: Molecular Imaging Reporter Core (MIRC)
-
批准号:7287034
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2007
-
负责人:David Piwnica-Worms
-
依托单位:
Administration
-
批准号:7287029
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2007
-
负责人:David Piwnica-Worms
-
依托单位:
Soc for Molecular Imaging 3rd Annual International Mtg
-
批准号:6877284
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2004
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6620939
-
项目类别:
-
资助金额:$183.3万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7795900
-
项目类别:
-
资助金额:$196.12万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7278495
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7498493
-
项目类别:
-
资助金额:$159.63万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:8181436
-
项目类别:
-
资助金额:$142.89万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:8101135
-
项目类别:
-
资助金额:$176.51万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6712737
-
项目类别:
-
资助金额:$220.1万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:6667006
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
Washington University Molecular Imaging Center
-
批准号:7026447
-
项目类别:
-
资助金额:$204.26万
-
财政年份:2002
-
负责人:David Piwnica-Worms
-
依托单位:
海外基金